Bionomics : Statutory Accounts - Form 6-K -September 29, 2023 at 10:53 am EDT
Statutory Accounts Directors Report In accordance with the Corporations Act 2001, the directors of...
Source: marketscreener.com
📰 Clinical Development News
Page 81 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
Pfizer's first acute migraine treatment recommended by NICE
The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).
Source: outsourcing-pharma.com
CymaBay launches study into drug for liver scarring
A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).
Kris Kowdley Charles Mcwherter Elsons Floyd College Of Medicine Washington State University Liver Institute Liver Institute Northwest
Source: outsourcing-pharma.com
Phesi and Krystelis partner to improve diversity in trials
A partnership has been formed between Phesi and Krsytelis, born out of a need to address the lack of diversity in clinical trials.
Source: outsourcing-pharma.com
Women in Science: ScaleReady's Jenny Stjernberg and her fervent passion for cell and gene therapies
At Advanced Therapies Europe 2023, BioPharma Reporter caught up with ScaleReady's Jenny Stjernberg to discuss her work at the biotech company, her journey from academia to commercial and female representation in the cell and gene therapies industry.
Source: outsourcing-pharma.com
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
CAMBRIDGE, Mass., Sept. 28, 2023 -- Synlogic, Inc. , a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious...
United States United Kingdom University Of Texas Neal Sondheimer Washington University University Of Pittsburgh
Source: marketscreener.com
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
28.09.2023 - CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) - Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced ... Seite 1
United States University Of Texas Neal Sondheimer Washington University University Of Florida University Of Pittsburgh
Source: wallstreet-online.de
Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs
/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the...
Source: prnewswire.com
PepGen Announces Upcoming Presentations at the 28th Annual Congress of the World Muscle Society and the World Congress of Neurology
BOSTON, Sept. 27, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...
Source: marketscreener.com
Novartis' Jakavi for treating rare blood cancer recommended
Patients with a rare and incurable blood cancer, associated with an overproduction of blood cells, will soon have access to a small molecule Novartis treatment.
United Kingdom City Of Jon Mathias Marie Andree Gamache Claire Harrison National Institute For Health
Source: outsourcing-pharma.com